1.78
前日終値:
$1.795
開ける:
$1.78
24時間の取引高:
406.30K
Relative Volume:
0.63
時価総額:
$66.83M
収益:
-
当期純損益:
-
株価収益率:
-
EPS:
-
ネットキャッシュフロー:
-
1週間 パフォーマンス:
+1.71%
1か月 パフォーマンス:
-21.24%
6か月 パフォーマンス:
+7.23%
1年 パフォーマンス:
-3.78%
Metagenomi Inc Stock (MGX) Company Profile
MGX を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
|
MGX
Metagenomi Inc
|
1.78 | 67.21M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
455.48 | 116.04B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
718.36 | 75.97B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
458.12 | 61.48B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
901.17 | 56.40B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
204.00 | 43.73B | 447.02M | -1.18B | -906.14M | -6.1812 |
Metagenomi Inc Stock (MGX) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-05-07 | 開始されました | H.C. Wainwright | Buy |
| 2024-05-02 | ダウングレード | JP Morgan | Overweight → Neutral |
| 2024-03-05 | 開始されました | BMO Capital Markets | Outperform |
| 2024-03-05 | 開始されました | Chardan Capital Markets | Buy |
| 2024-03-05 | 開始されました | JP Morgan | Overweight |
| 2024-03-05 | 開始されました | Jefferies | Buy |
| 2024-03-05 | 開始されました | TD Cowen | Outperform |
| 2024-03-05 | 開始されました | Wells Fargo | Overweight |
すべてを表示
Metagenomi Inc (MGX) 最新ニュース
Will Metagenomi Inc. stock deliver consistent dividendsBull Run & Technical Pattern Based Signals - Newser
Pura Vida Investments LLC Grows Stock Position in Metagenomi, Inc. $MGX - MarketBeat
Metagenomi’s general counsel Wein sells $360 in stock By Investing.com - Investing.com Nigeria
Thomas Brian C. sells Metagenomi (MGX) shares worth $4888 By Investing.com - Investing.com Canada
Irish Jian, Metagenomi CEO, sells $2899 in MGX stock By Investing.com - Investing.com Canada
Metagenomi CFO Wapnick sells $2852 in shares By Investing.com - Investing.com Canada
Thomas Brian C. sells Metagenomi (MGX) shares worth $4888 - Investing.com India
Metagenomi CFO Wapnick sells $2852 in shares - Investing.com
Irish Jian, Metagenomi CEO, sells $2899 in MGX stock - Investing.com
CEO Irish Surrenders 1,602 Of Metagenomi Inc [MGX] - TradingView
Metagenomi’s general counsel Wein sells $360 in stock - Investing.com
Metagenomi (Nasdaq: MGX) to unveil APOC3 preclinical data from Ionis collaboration at 2025 Nature conference - Stock Titan
Why analysts upgrade Metagenomi Inc. stock2025 Technical Overview & Free Real-Time Market Sentiment Alerts - BỘ NỘI VỤ
Will Metagenomi Inc. stock attract ESG investorsQuarterly Earnings Report & Reliable Intraday Trade Plans - BỘ NỘI VỤ
Metagenomi, Inc. (MGX) 5.71% in After-hours: Strong Investor Interest - Stocks Telegraph
Metagenomi Inc Stock Analysis and ForecastMomentum Trading Signals & Predict Price Movements With AI Precision - earlytimes.in
Why Metagenomi Inc. stock could rally in 2025July 2025 Volume & Verified High Yield Trade Plans - newser.com
Market reaction to Metagenomi Inc.’s recent newsLong Setup & Weekly Setup with ROI Potential - newser.com
What sentiment indicators say about Metagenomi Inc. stockJuly 2025 Movers & Technical Pattern Based Buy Signals - newser.com
How to forecast Metagenomi Inc. trends using time seriesBull Run & Free Expert Approved Momentum Trade Ideas - newser.com
Is Metagenomi Inc. stock a safe haven assetQuarterly Trade Review & Free Daily Entry Point Trade Alerts - newser.com
How Metagenomi Inc. stock performs in stagflationQuarterly Profit Report & Capital Efficiency Focused Strategies - newser.com
Is Metagenomi Inc. stock gaining market shareJuly 2025 Breakouts & Technical Buy Zone Confirmations - newser.com
Exit strategy if you’re trapped in Metagenomi Inc.Market Trend Review & Weekly Hot Stock Watchlists - newser.com
How Metagenomi Inc. stock performs in rising dollar environmentJuly 2025 Selloffs & Expert-Curated Trade Recommendations - newser.com
Using AI based signals to follow Metagenomi Inc.July 2025 Market Mood & Low Drawdown Momentum Ideas - newser.com
Ready to Jump After Recent Trade: Metagenomi Inc (MGX) - Setenews
Jefferies lowers Metagenomi stock price target to $9 from $21 on pipeline timing - Investing.com Nigeria
Metagenomi to Present at Jefferies Global Healthcare Conference in London - The Manila Times
The Impact Of Rising Infectious Disease Incidence On - openPR.com
Metagenomi, Inc. (NASDAQ:MGX) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat
Rx Rundown: Metagenomi, Chiesi, Thermo Fisher Scientific and more - Medical Marketing and Media
Metagenomi Inc (MGX) 財務データ
Metagenomi Inc (MGX) の財務データはありません。詳細については、他の銘柄を確認してください。
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):